Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

6527.TWO

STRONG BUYREMOVE

Crystalvue Medical Corporation · Healthcare · Taiwan · $57M · Avg Vol: $69K/d

81
StockRank
Q
69
V
64
M
37
P/E (TTM)
12.6x
ROE
15.1%
D/E
0.0x
Dividend %
4.1%
AI CONVICTION THESIS

Crystalvue Medical is a high-quality manufacturer of ophthalmic devices with decent quantitative scores. However, it is a micro-cap stock with limited liquidity and lacks any connection to our 18-month macro themes, failing the Druckenmiller lens.

COMPANY DESCRIPTION

Crystalvue Medical Corporation develops and manufactures advanced ophthalmic medical devices, specializing in automatic fundus cameras and optical coherence tomography (OCT) systems. The company's competitive moat is established through proprietary optical design, precision manufacturing, and the integration of AI-driven diagnostic software. Crystalvue operates as a high-growth niche player, supplying global medical device distributors and healthcare networks.

FINANCIAL SUMMARY (USD)

Year20212022202320242025CAGR
Revenue25.1M26.0M27.4M30.0M6.1%
EPS0.100.150.130.1617.6%
Shares25.5M25.5M25.3M25.5M-0.1%
Debt1.0M0.8M0.6M0.4M-28.0%
Equity24.5M27.1M29.7M32.5M9.9%
Op CF1.6M4.9M4.8M4.4M39.0%
Inv CF-0.1M-0.3M-4.1M-5.8M
Fin CF-2.0M-1.5M-1.8M-2.0M
Loading...
PRICE (1Y)+3.4%
2.182.222.252.282.32May 14Jun 4Jun 25
SMA 50SMA 200
Close
$2.28
RSI (14)
59.7
52W High
$2.87
From 52W High
0.8%

SCORE BREAKDOWN

Quality
69
ROIC
17.4%88.9
ROE
15.1%83.0
GP/Assets
25.4%57.4
Op. Margin
20.1%82.7
FCF/Assets
-6.4%33.4
Piotroski
666.7
Int. Cover
50.0x88.4
D/E Ratio
0.01x88.4
Current Ratio
1.75x31.9
Value
64
P/E (TTM)
12.6x80.6
EV/EBITDA
9.4x70.5
P/FCF
N/A
P/B
1.9x62.5
P/S
2.0x67.8
Div Yield
4.1%84.2
Momentum
37
52W High %
80%72.1
RS 6M
-73%13.0
SMA 50/200
0.91x37.3
EPS Rev 4W
+0.5%74.2
EPS Rev 12W
N/A
EPS Improve
19.0
Q Growth
-8%33.3

FUNDAMENTALS

Market Cap
$57M
P/E (Forward)
13.3x
Gross Margin
35.8%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 6527.TWO are excluded.

TickerCompanyMkt CapStockRankSignal
6527.TWOCrystalvue Medical Corporation(you)$57M81STRONG BUY
1783.TWMaxigen Biotech Inc.$109M80STRONG BUY
9103.TWMedtecs International Corporation Limited$90M65BUY
4126.TWOPacific Hospital Supply Co., Ltd$184M86STRONG BUY
1752.TWNang Kuang Pharmaceutical Co., Ltd.$104M62HOLD
1565.TWOSt.Shine Optical Co.,Ltd.$149M63HOLD
4771.TWVizionfocus Inc.$357M87STRONG BUY
4107.TWOBioteque Corporation$254M95STRONG BUY
6782.TWVisco Vision Inc.$393M99STRONG BUY
6491.TWPegavision Corporation$794M87STRONG BUY

Peer medians: ROE 3.4% · P/E 16.4x · Gross margin 42.1%

Crystalvue Medical Corporation (6527.TWO) — Stock Score Summary

Crystalvue Medical Corporation (6527.TWO) has a MoatMap StockRank of 81/100 based on Quality (69/100), Value (64/100), and Momentum (37/100) factor scores. The current signal is STRONG BUY. Crystalvue Medical is a high-quality manufacturer of ophthalmic devices with decent quantitative scores. However, it is a micro-cap stock with limited liquidity and lacks any connection to our 18-month macro themes, failing the Druckenmiller lens.

Crystalvue Medical Corporation develops and manufactures advanced ophthalmic medical devices, specializing in automatic fundus cameras and optical coherence tomography (OCT) systems. The company's competitive moat is established through proprietary optical design, precision manufacturing, and the integration of AI-driven diagnostic software. Crystalvue operates as a high-growth niche player, supplying global medical device distributors and healthcare networks.

Key Financial Metrics

Price$2.28
Market Cap$57M
P/E (TTM)12.63
P/E (Forward)13.31
Price/Book1.85
Return on Equity15.1%
Return on Invested Capital17.4%
Debt/Equity1.01
Gross Margin35.8%
Operating Margin20.1%
Revenue Growth-16.1%
Dividend Yield4.1%
Free Cash Flow$-83K

Crystalvue Medical Corporation operates in the Medical Instruments & Supplies industry, part of the Healthcare sector (Taiwan).

Frequently Asked Questions

What is Crystalvue Medical Corporation’s (6527.TWO) StockRank?
MoatMap’s StockRank for Crystalvue Medical Corporation (6527.TWO) is 81/100, with a Strong Buy signal. It is a composite of Quality (69), Value (64), and Momentum (37) factor ranks across MoatMap’s 20,000+ stock universe.
Does Crystalvue Medical Corporation have an economic moat?
Crystalvue Medical Corporation (6527.TWO) has a Quality factor score of 69/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Crystalvue Medical Corporation a buy, hold, or sell?
MoatMap’s current signal for Crystalvue Medical Corporation (6527.TWO) is Strong Buy, based on a StockRank of 81/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Crystalvue Medical Corporation in?
Crystalvue Medical Corporation (6527.TWO) operates in the Healthcare sector, specifically the Medical Instruments & Supplies industry (Taiwan).